Ectopic Cushing's Syndrome from ACTH-Producing Pheochromocytoma
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Background:
ACTH-dependent Cushing’s syndrome results from
excessive ACTH secretion from a pituitary gland
adenoma (Cushing’s disease) in 80% of cases. Much
less commonly, ectopic ACTH production occurs outside
.
the pituitary gland, with the majority of those cases
caused by bronchial carcinoids. A small number are due
to excessive ACTH secretion by a pheochromocytoma.
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Case presentation:
A 48-year-old female was transferred from an outside
hospital where a diagnosis of adrenal mass was made.
She initially presented to the outside hospital with
orthostatic hypotension, episodic tachycardia, easy
bruising, new-onset hypokalemia, and unintentional
weight loss. She had a history of uncontrolled
hypertension, right foot amputation after an embolic
event, type 2 diabetes, and three myocardial infarctions.
She was adopted and did not know her family history.
Her medications were lisinopril, verapamil, metoprolol,
gabapentin, warfarin, metformin, clopidogrel, simvastatin,
and potassium. Physical exam revealed facial plethora,
mild central obesity, and livedo reticularis. No
dorsocervical fat pad or abdominal striae were noted. BP
was 217/99 mm Hg and pulse was 108. Abdominal CT
performed at the outside hospital showed a 7.2 x 5.6 x
8.5 cm heterogeneous mass originating from the right
adrenal gland, with a density of 44 Hounsfield units. No
IV contrast was given due to IV contrast allergy. Chest
CT at the outside hospital was negative for any
pathology. Abdominal MRI at our hospital showed similar
findings as the abdominal CT scan. Serology results:
Plasma free metanephrines 8680 pg/mL, plasma free
normetanephrines 5400 pg/mL, renin 31.89 ng/mL/h,

(A) ACTH expression in pheochromocytoma: The pheochromocytoma demonstrates strong immunoreactivity for
ACTH, whereas the surrounding adrenal gland is negative (original magnification 200X)
(B) Pheochromocytoma: There is a clear separation between the pheochromocytoma and adjacent adrenal gland
by a thin fibrous capsule (Hematoxylin and eosin, original magnification 40X)
(C, D) The tumor consists of large cells with abundant basophilic cytoplasm. Prominent nucleoli are evident.
Occasional tumor giant cells are present. (Hematoxylin and eosin, original magnification 200X and 400X).

aldosterone 6 ng/dL, chromogranin A 192.8 ng/mL, TSH 0.65 UIU/L, HbA1c
8.3%, serum potassium 2.3 mmol/L. Urine studies: metanephrines 13373
mcg/24 h, normetanephrines 12077 mcg/24 h, total metanephrines 25450
mcg/24 h. Catecholamines were not performed due to order entry error by
the primary service in the hospital. I-123 MIBG scan revealed intense uptake
in the right adrenal gland without metastases.
The patient’s serum potassium of 2.3 mmol/L led to further evaluation
revealing morning serum cortisol of 165.4 mcg/dL and ACTH of 1103 pg/mL;
these extremely elevated levels were highly suggestive of an ectopic ACTH
source. 24 hour urine free cortisol was 3200 mcg/24 h.
Given the short time frame for surgical preparation, the patient was begun on
both preoperative phenoxybenzamine 20 mg twice daily and metyrosine for
alpha-adrenergic blockade and decrease of endogenous catecholamines.
We followed the Mayo Clinic protocol for metyrosine preparation: 250 mg
every six hours on day one, 500 mg every six hours on day two, 750 mg

every six hours on day three, and 1000 mg every six
hours on the day before the procedure, with the last
dose (1000 mg) the morning of the procedure. With
stress-dose IV hydrocortisone given perioperatively,
she underwent surgical excision of a right
pheochromocytoma, measuring 10 cm on pathology
with margins microscopically free of neoplasm and
no evidence of vascular or capsular invasion.
Immunohistochemical stain for ACTH was strongly
positive. She was discharged on dexamethasone
0.5 mg daily. Three weeks postoperatively, the
patient was able to discontinue all BP medicines and
her symptoms and signs of Cushing’s syndrome had
significantly improved. Potassium, plasma free
metanephrines, and urinary catecholamines and
metanephrines were normal. Cortisol and ACTH
were undetectable. She was advised to remain on
maintenance glucocorticoids until her HPA axis
recovered and have regular follow-up for possible
pheochromocytoma recurrence.

Conclusion:
A high index of suspicion is required to diagnose
ectopic Cushing’s syndrome due to excessive ACTH
secretion by a pheochromocytoma. Correct
perioperative management is essential to avoid
complications.
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